Hollings Renton, President and CEO at ONYX PHARMACEUTICALS INC (ONXX), sold 666 shares at $58.70 ($39K) on 2007-11-16, disclosed to the SEC on 2007-11-19.
Scheduled sale ($39k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |